Literature DB >> 14502780

Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET).

Toshimori Koh1, Hiroki Taniguchi, Akihiro Yamaguchi, Satoshi Kunishima, Hisakazu Yamagishi.   

Abstract

BACKGROUND AND OBJECTIVES: The purpose of this paper is to evaluate the utility of positron emission tomography (PET) with fluorine-18-labeled fluoro-deoxyglucose (FDG) in the preoperative differential diagnosis of gallbladder tumors. We performed PET studies of gallbladder tumors in order to predict the malignancy of these tumors preoperatively.
METHODS: Sixteen patients who had protuberant lesions in the gallbladder and who were scheduled to undergo surgery were studied with PET using FDG. Focally increased FDG uptake in the gallbladder region was considered malignant. The FDG-PET findings were compared with the histological findings of surgical pathology.
RESULTS: Sensitivity of FDG-PET was 75% (6/8 patients). One of two false-negative cases suffered from diabetes mellitus, and in the other case, the lesion was small. Specificity was 87.5% (7/8 patients). A case with xanthogranulomatous cholecystitis (XGC) was the only false-positive case.
CONCLUSIONS: FDG-PET may be able to provide important information for evaluating the malignancy of gallbladder tumors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502780     DOI: 10.1002/jso.10295

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  27 in total

1.  Successful diagnosis of gallbladder carcinoma coexisting with adenomyomatosis by 18F-FDG-PET--report of a case.

Authors:  Keiichi Suzuki; Susumu Watada; Mitsui Yoko; Tadaki Nakahara; Yusuke Kumamoto
Journal:  J Gastrointest Cancer       Date:  2011-12

2.  Gallbladder tuberculosis: false-positive PET diagnosis of gallbladder cancer.

Authors:  J M Ramia; K Muffak; A Fernández; J Villar; D Garrote; J A Ferron
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

3.  Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening.

Authors:  Vikas Gupta; K S Vishnu; Thakur D Yadav; Yashwant R Sakaray; Santosh Irrinki; B R Mittal; N Kalra; K Vaiphei
Journal:  J Gastrointest Cancer       Date:  2019-12

4.  Xanthogranulomatous cholecystitis complicated with primary sclerosing cholangitis: report of a case.

Authors:  Akira Mori; Ryuichiro Doi; Yoshikuni Yonenaga; Shuichiro Nakabo; Shujiro Yazumi; Junya Nakaya; Fumihiko Kono; Toshiaki Manabe; Shinji Uemoto
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

5.  FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

Authors:  Koji Murakami
Journal:  World J Clin Oncol       Date:  2011-05-10

6.  Strategies for Differentiating Gallbladder Carcinoma from Xanthogranulomatous Cholecystitis-a Tertiary Care Centre Experience.

Authors:  Rajaguru Kishore; Samiran Nundy; Siddharth Mehrotra; Naimish Metha; Vivek Mangla; Shailendra Lalwani
Journal:  Indian J Surg Oncol       Date:  2017-07-27

Review 7.  Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.

Authors:  Amit Nandan Dhar Dwivedi; Shivi Jain; Ruhi Dixit
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

8.  Xanthogranulomatous cholecystitis mimicking gallbladder cancer.

Authors:  Ofor Ewelukwa; Omair Ali; Salma Akram
Journal:  BMJ Case Rep       Date:  2014-05-08

9.  Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer?

Authors:  Parul J Shukla; Savio G Barreto; Supreeta Arya; Shailesh V Shrikhande; Rohini Hawaldar; Nilendu Purandare; Venkatesh Rangarajan
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Gallbladder cancer revealed by an endobiliary tumor thrombus.

Authors:  David Fuks; Vijay Borgaonkar; Sushil Deshpande; Vaishali Deshpande; Charlotte Mouly; Viraj Borgaonkar; Francois Mauvais; Vaishali Jadhav; Jean-Marc Regimbeau
Journal:  Indian J Surg       Date:  2012-12-09       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.